دورية أكاديمية

Markets, incentives, and health promotion can improve family planning and maternal health practices: a quasi-experimental evaluation of a tech-enabled social franchising and social marketing platform in India.

التفاصيل البيبلوغرافية
العنوان: Markets, incentives, and health promotion can improve family planning and maternal health practices: a quasi-experimental evaluation of a tech-enabled social franchising and social marketing platform in India.
المؤلفون: Patil SR; NEERMAN Pvt Ltd, Mumbai, India. srpatil@neerman.org., Gopalakrishnan L; NEERMAN Pvt Ltd, Mumbai, India.; University of California San Francisco, San Francisco, USA., Sai VS; NEERMAN Pvt Ltd, Mumbai, India., Matikanya R; Triggerise BV, Amsterdam, The Netherlands., Rajpal P; BBC Media Action, New Delhi, India.
المصدر: BMC public health [BMC Public Health] 2024 Jan 23; Vol. 24 (1), pp. 264. Date of Electronic Publication: 2024 Jan 23.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: Family Planning Services* , Social Marketing*, Pregnancy ; Female ; Humans ; Ecosystem ; Maternal Health ; Motivation ; Retrospective Studies ; Health Promotion ; Contraceptive Agents ; India
مستخلص: Background: Improving family planning and maternal health outcomes are critical to achieving the Sustainable Development Goals. While evidence on the effectiveness of government-driven public health programs is extensive, more research is needed on effectiveness of private-sector interventions, especially in low- and middle-income countries. We evaluated the impacts of a commercial social-franchising and social-marketing program - Tiko Platform - which created a local ecosystem of health promoters, healthcare providers, pharmacies, stockists/wholesalers, and lifestyle shops. It provided economic incentives through discounts and reward points to nudge health-seeking behaviors from enrolled women consumers/beneficiaries.
Methods: An ex-post facto evaluation was commissioned, and we employed a quasi-experimental design to compare outcomes related to the use of family planning, and antenatal and postnatal services between users and non-users who had registered for Tiko in three North Indian cities. Between March and April 2021, 1514 married women were surveyed, and outcome indicators were constructed based on recall. Despite statistical approaches to control for confounding, the effect of COVID-19 lockdown on Tiko operations and methodological limitations preclude inferring causality or arguing generalizability.
Results: We found a strong association between the use of the Tiko platform and the current use of temporary modern contraceptives [non-users: 9.5%, effect: +9.4 percentage points (pp), p-value < 0.001], consumption of 100 or more iron-folic-acid tablets during pregnancy [non-users: 25.5%, effect: +14 pp, p-value < 0.001], receiving four or more antenatal check-ups [non-users: 18.3%, effect: +11.3 pp, p-value 0.007], and receiving postnatal check-up within six weeks of birth [non-users: 50.9%, effect: +7.5 pp, p-value 0.091]. No associations were found between the use of the Tiko platform and the current use of any type of contraceptive (temporary, permanent, or rudimentary). Effects were pronounced when a community health worker of the National Health Mission also worked as a health promoter for the Tiko Platform.
Conclusion: Commercial interventions that harness market-driven approaches of incentives, social marketing, and social franchising improved family planning and maternal health practices through higher utilization of private market providers while maintaining access to government health services. Findings support a unifying approach to public health without separating government versus private services, but more rigorous and generalizable research is needed.
Trial Registration: NCT05725278 at clinicaltrials.gov (retrospective); 13/02/2023.
(© 2024. The Author(s).)
References: PLoS Med. 2008 Nov 25;5(11):e233. (PMID: 19067483)
J Mark. 1971 Jul;35(3):3-12. (PMID: 12276120)
Glob Health Sci Pract. 2015 Jun 17;3(2):195-208. (PMID: 26085018)
BMC Pregnancy Childbirth. 2021 May 19;21(1):389. (PMID: 34011316)
J Health Popul Nutr. 2016 Jun 18;35(1):19. (PMID: 27316700)
BMJ Open. 2017 Nov 15;7(11):e017122. (PMID: 29146636)
BMJ Glob Health. 2021 Apr;6(4):. (PMID: 33846142)
Health Policy Plan. 2017 Feb;32(1):110-124. (PMID: 27476502)
BMJ. 2013 Jun 21;346:f3443. (PMID: 23794316)
J Biosoc Sci. 2020 May;52(3):338-352. (PMID: 31328714)
PLoS One. 2013 Sep 12;8(9):e74260. (PMID: 24069287)
Fertil Steril. 2021 Oct;116(4):1128-1138. (PMID: 34325920)
PLoS One. 2015 Sep 30;10(9):e0139288. (PMID: 26422685)
BMC Health Serv Res. 2018 Sep 10;18(1):699. (PMID: 30200964)
Indian J Med Res. 2018 Dec;148(Suppl):S1-S9. (PMID: 30964076)
BMC Womens Health. 2016 Jan 15;16:2. (PMID: 26772591)
Lancet Glob Health. 2018 Feb;6(2):e211-e221. (PMID: 29275135)
Health Res Policy Syst. 2004 Jul 28;2(1):5. (PMID: 15282025)
Health Res Policy Syst. 2010 Jul 15;8:24. (PMID: 20630108)
Lancet. 2012 Jul 14;380(9837):165-71. (PMID: 22784535)
Indian J Med Res. 2014 Nov;140 Suppl:S137-46. (PMID: 25673535)
BMC Med Res Methodol. 2009 Jun 18;9:39. (PMID: 19538744)
JAMA. 2006 Apr 19;295(15):1809-23. (PMID: 16622143)
PLoS One. 2021 Jan 13;16(1):e0243854. (PMID: 33439888)
Stud Fam Plann. 2010 Dec;41(4):241-50. (PMID: 21465725)
Reprod Health. 2014 Jan 02;11(1):1. (PMID: 24383405)
PLoS One. 2013 Apr 23;8(4):e60669. (PMID: 23637757)
Indian J Med Res. 2014 Nov;140 Suppl:S147-51. (PMID: 25673536)
BMJ Glob Health. 2019 May 4;4(3):e001162. (PMID: 31139464)
Stud Fam Plann. 2014 Sep;45(3):301-14. (PMID: 25207494)
Midwifery. 2021 Dec;103:103107. (PMID: 34358778)
فهرسة مساهمة: Keywords: Community health workers; Family planning; Market-driven approaches; Maternal health; Private sector; Public health; Social franchising; Social marketing
سلسلة جزيئية: ClinicalTrials.gov NCT05725278
المشرفين على المادة: 0 (Contraceptive Agents)
تواريخ الأحداث: Date Created: 20240123 Date Completed: 20240125 Latest Revision: 20240209
رمز التحديث: 20240209
مُعرف محوري في PubMed: PMC10804567
DOI: 10.1186/s12889-023-17413-w
PMID: 38262982
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-2458
DOI:10.1186/s12889-023-17413-w